Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Sales

Avricore Health (AVCRF) Invested Capital (2016 - 2025)

Avricore Health has reported Invested Capital over the past 12 years, most recently at $279351.0 for Q4 2025.

  • Quarterly Invested Capital fell 80.17% to $279351.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $279351.0 through Dec 2025, down 80.17% year-over-year, with the annual reading at $278819.3 for FY2025, 80.6% down from the prior year.
  • Invested Capital was $279351.0 for Q4 2025 at Avricore Health, down from $1.4 million in the prior quarter.
  • Over five years, Invested Capital peaked at $2.0 million in Q1 2021 and troughed at $29587.9 in Q1 2023.
  • The 5-year median for Invested Capital is $1.4 million (2023), against an average of $995881.7.
  • Year-over-year, Invested Capital plummeted 98.44% in 2022 and then surged 4391.26% in 2023.
  • A 5-year view of Invested Capital shows it stood at $1.8 million in 2021, then fell by 16.8% to $1.5 million in 2022, then rose by 9.69% to $1.6 million in 2023, then fell by 13.02% to $1.4 million in 2024, then tumbled by 80.17% to $279351.0 in 2025.
  • Per Business Quant, the three most recent readings for AVCRF's Invested Capital are $279351.0 (Q4 2025), $1.4 million (Q4 2024), and $1.6 million (Q4 2023).